CID 16204697

5'-dtttttttttt-3', phosphorothioate oligodeoxynucleotide

Structural Information

Molecular Formula
C100H131N20O59P9S9
SMILES
CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=S)(O)OC3CC(OC3COP(=S)(O)OC4CC(OC4COP(=S)(O)OC5CC(OC5COP(=O)(OC6CC(OC6COP(=S)(O)OC7CC(OC7COP(=S)(O)OC8CC(OC8COP(=S)(O)OC9CC(OC9COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1CO)N1C=C(C(=O)NC1=O)C)N1C=C(C(=O)NC1=O)C)N1C=C(C(=O)NC1=O)C)N1C=C(C(=O)NC1=O)C)N1C=C(C(=O)NC1=O)C)N1C=C(C(=O)NC1=O)C)S)N1C=C(C(=O)NC1=O)C)N1C=C(C(=O)NC1=O)C)N1C=C(C(=O)NC1=O)C)O
InChI
InChI=1S/C100H131N20O59P9S9/c1-41-21-111(91(133)101-81(41)123)71-11-51(122)62(162-71)32-152-180(143,189)172-53-13-73(113-23-43(3)83(125)103-93(113)135)164-64(53)34-154-182(145,191)174-55-15-75(115-25-45(5)85(127)105-95(115)137)166-66(55)36-156-184(147,193)176-57-17-77(117-27-47(7)87(129)107-97(117)139)168-68(57)38-158-186(149,195)178-59-19-79(119-29-49(9)89(131)109-99(119)141)170-70(59)40-160-188(151,197)179-60-20-80(120-30-50(10)90(132)110-100(120)142)169-69(60)39-159-187(150,196)177-58-18-78(118-28-48(8)88(130)108-98(118)140)167-67(58)37-157-185(148,194)175-56-16-76(116-26-46(6)86(128)106-96(116)138)165-65(56)35-155-183(146,192)173-54-14-74(114-24-44(4)84(126)104-94(114)136)163-63(54)33-153-181(144,190)171-52-12-72(161-61(52)31-121)112-22-42(2)82(124)102-92(112)134/h21-30,51-80,121-122H,11-20,31-40H2,1-10H3,(H,143,189)(H,144,190)(H,145,191)(H,146,192)(H,147,193)(H,148,194)(H,149,195)(H,150,196)(H,151,197)(H,101,123,133)(H,102,124,134)(H,103,125,135)(H,104,126,136)(H,105,127,137)(H,106,128,138)(H,107,129,139)(H,108,130,140)(H,109,131,141)(H,110,132,142)
InChIKey
VHENQZKAOWMKBA-UHFFFAOYSA-N
Compound name
1-[4-hydroxy-5-[[hydroxy-[2-[[hydroxy-[2-[[hydroxy-[2-[[[2-[[hydroxy-[2-[[hydroxy-[2-[[hydroxy-[2-[[hydroxy-[2-[[hydroxy-[2-(hydroxymethyl)-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxyphosphinothioyl]oxymethyl]-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxyphosphinothioyl]oxymethyl]-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxyphosphinothioyl]oxymethyl]-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxyphosphinothioyl]oxymethyl]-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxyphosphinothioyl]oxymethyl]-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxy-sulfanylphosphoryl]oxymethyl]-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxyphosphinothioyl]oxymethyl]-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxyphosphinothioyl]oxymethyl]-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxyphosphinothioyl]oxymethyl]oxolan-2-yl]-5-methylpyrimidine-2,4-dione
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

1
References

0
Patents

3122.299 Da
Monoisotopic Mass

-1.2
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 3123.3063 296.6
[M+Na]+ 3145.2882 304.1
[M-H]- 3121.2917 300.6
[M+NH4]+ 3140.3328 299.9
[M+K]+ 3161.2622 299.2
[M+H-H2O]+ 3105.2963 297.6
[M+HCOO]- 3167.2972 300.0
[M+CH3COO]- 3181.3129 300.3
[M+Na-2H]- 3143.2737 305.7
[M]+ 3122.2985 302.6
[M]- 3122.2995 302.6
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

No patent data available for this compound.